ArticleMalaria journal2018

A bioreactor system for the manufacture of a genetically modified Plasmodium falciparum blood stage malaria cell bank for use in a clinical trial.

Rebecca Pawliw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.